BPG is committed to discovery and dissemination of knowledge
Articles Published Processes
11/11/2015 1:33:00 PM | Browse: 908 | Download: 1198
Publication Name World Journal of Gastroenterology
Manuscript ID 18947
Country/Territory Iran
Received
2015-04-29 13:47
Peer-Review Started
2015-05-07 09:28
To Make the First Decision
2015-06-02 15:12
Return for Revision
2015-06-09 12:47
Revised
2015-07-19 04:14
Second Decision
2015-09-12 22:02
Accepted by Journal Editor-in-Chief
Accepted by Company Editor-in-Chief
2015-09-14 11:31
Articles in Press
2015-09-14 11:32
Publication Fee Transferred
Edit the Manuscript by Language Editor
2015-09-28 09:39
Typeset the Manuscript
2015-10-22 19:56
Publish the Manuscript Online
2015-11-11 13:34
ISSN 1007-9327 (print) and 2219-2840 (online)
Open Access This article is an open-access article which was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/
Copyright © The Author(s) 2015. Published by Baishideng Publishing Group Inc. All rights reserved.
Article Reprints For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
Permissions For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
Publisher Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
Website http://www.wjgnet.com
Category Virology
Manuscript Type Topic Highlights
Article Title Progress in the development of vaccines for hepatitis C virus infection
Manuscript Source Invited Manuscript
All Author List Faezeh Ghasemi, Sina Rostami and Zahra Meshkat
Funding Agency and Grant Number
Corresponding Author Zahra Meshkat, PhD, Antimicrobial Resistance Research Center, Faculty of Medicine, Mashhad University of Medical Sciences, Mashhad 9196773117, Iran. meshkatz@mums.ac.ir
Key Words Preventive vaccine; Therapeutic vaccine; Hepatitis C virus; Hepatitis C virus infection
Core Tip Chronic hepatitis C virus (HCV) infection occurs in about 75%-90% of acutely infected individuals. It may progress to liver cirrhosis or hepatocellular carcinoma. Despite satisfactory progress in the management and treatment of chronic hepatitis C, it remains one of the most prominent viral infections worldwide. Although no reliable vaccine for it has yet been developed, researchers are trying to design and develop different types of vaccines to prevent HCV infection or to cure the chronic form of the disease. The current article provides an overview of the latest progress in the development of preventive and therapeutic vaccines against HCV infection in the context of peptide vaccines, recombinant protein vaccines, HCV-like particle, DNA vaccines, and viral vectors expressing HCV genes.
Publish Date 2015-11-11 13:34
Citation Ghasemi F, Rostami S, Meshkat Z. Progress in the development of vaccines for hepatitis C virus infection. World J Gastroenterol 2015; 21(42): 11984-12002
URL http://www.wjgnet.com/1007-9327/full/v21/i42/11984.htm
DOI http://dx.doi.org/10.3748/wjg.v21.i42.11984
Full Article (PDF) WJG-21-11984.pdf
Full Article (Word) WJG-21-11984.doc
Manuscript File 18947-Review.docx
Answering Reviewers 18947-Answering reviewers.pdf
Audio Core Tip 18947-Audio core tip.mp3
Conflict-of-Interest Disclosure Form 18947-Conflict-of-interest statement.pdf
Copyright License Agreement 18947-Copyright assignment.pdf
Non-Native Speakers of English Editing Certificate 18947-Language certificate.pdf
Peer-review Report 18947-Peer-review(s).pdf
Scientific Misconduct Check 18947-Scientific misconduct check.pdf
Scientific Editor Work List 18947-Scientific editor work list.pdf